Form 4 for PRLD Prelude Therapeutics Inc
Accepted 2021-12-17 00:00:00 ET · period of report 2021-12-15 · accession 0001209191-21-070352 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-17 | 2021-12-15 | PRLD | Morosini Deborah | EVP, Chief of Clinical Affairs | M - OptEx | $11.70 | +28.8K | 3,460 | New | +$336.4K |
| D | 2021-12-17 | 2021-12-15 | PRLD | Morosini Deborah | EVP, Chief of Clinical Affairs | S - Sale+OE | $13.00 | -28.8K | 444 | -98% | -$373.8K |
| DM | 2021-12-17 | 2021-12-15 | PRLD | Morosini Deborah | EVP, Chief of Clinical Affairs | M - OptEx | $0.00 | -28.8K | 74.6K | -28% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-15 | M | A | 25,735 | $12.85 | 29,195 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-15 | S | D | 28,751 | $13.00 | 444 | D | — | — | |
| 3 | Common | Common Stock | 2021-12-15 | M | A | 3,016 | $1.89 | 3,460 | D | — | — | |
| 4 | Derivative | Employee Stock Option (right to buy) | 2021-12-15 | M | D | 3,016 | $0.00 | 1,307 | D | $1.89 · — to 2030-03-26 | 3,016 Common Stock | (F2) The stock option is fully vested. |
| 5 | Derivative | Employee Stock Option (right to buy) | 2021-12-15 | M | D | 882 | $0.00 | 195,163 | D | $12.85 · — to 2030-09-01 | 882 Common Stock | (F4) The stock option vests as to 25% of the total shares monthly beginning on July 27, 2020, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2021-12-15 | M | D | 24,853 | $0.00 | 74,575 | D | $12.85 · — to 2030-09-01 | 24,853 Common Stock | (F3) The stock option vests as to 25% of the total shares monthly beginning on September 24, 2021, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date. |